CSIMarket



Best Performing Stocks In Medical Laboratories Industry During This Month Of July



 1 Day   Week  Current Month of July  30 Days 
Current Quarter Q3 of 2024  90 Days    Ytd    12 Months 
 

Shares are up by 5.45% on average, in Medical Laboratories Industry during this month of July.

Here are the best performing stocks in Medical Laboratories Industry.




PSNL

$3.85

$2.6550 222.18%
This Month of July


PSNL

$3.85

$2.6550 222.18%



Personalis Inc

Personalis Inc stock improved 222.18% during this month of July.


Personalis Inc*s business model revolves around offering advanced genomic sequencing and data analysis solutions to empower researchers and healthcare providers in their efforts to develop precision medicine and personalized therapies.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 187.473 mill. $ 70.528 mill. $ -112.780 mill. 49 mill. - Y/Y 22.81 %
Market Cap. Revenues TTM Net Income TTM

$ 187.473 mill.


$ 70.528 mill.


$ -112.780 mill.

Employees Shares Outstanding P/E

-


49 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 22.81 %


MRQ Y/Y - %



ABSI

$3.97

$0.9600 31.89%
This Month of July


ABSI

$3.97

$0.9600 31.89%



Absci Corp

Absci Corp stock went up 31.89% during this month of July.


Absci Corp*s business model focuses on driving innovation in drug discovery and development through their integrated synthetic biology platform. They offer a comprehensive suite of services that enable clients to rapidly and efficiently discover, develop, and manufacture new biotherapeutics.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 394.592 mill. $ 5.347 mill. $ -109.186 mill. 99 mill. - Y/Y -29.24 %
Market Cap. Revenues TTM Net Income TTM

$ 394.592 mill.


$ 5.347 mill.


$ -109.186 mill.

Employees Shares Outstanding P/E

-


99 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -29.24 %


MRQ Y/Y - %



SERA

$7.8

$1.7600 29.14%
This Month of July


SERA

$7.8

$1.7600 29.14%



Sera Prognostics Inc

Sera Prognostics Inc stock improved 29.14% during this month of July.


Sera Prognostics Inc has a business model that focuses on developing and commercializing innovative diagnostic tests for predicting pregnancy complications.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 251.316 mill. $ - mill. $ -33.774 mill. 32 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 251.316 mill.


$ - mill.


$ -33.774 mill.

Employees Shares Outstanding P/E

-


32 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



CNTG

$0.52

$0.1101 26.86%
This Month of July


CNTG

$0.52

$0.1101 26.86%



Centogene N v

Centogene N V shares increased 26.86% during this month of July.


Centogene N v operates in the field of rare genetic diseases, offering genetic testing and diagnostics services to patients, healthcare providers, and pharmaceutical companies. Their business model involves leveraging their extensive knowledge and expertise in genetic analysis and interpreting data to provide accurate diagnoses and personalized treatment options for individuals with rare genetic disorders. Additionally, they collaborate with pharmaceutical companies to assist in drug development and clinical trials for rare diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 14.549 mill. $ 54.319 mill. $ -39.796 mill. 28 mill. - Y/Y 2.16 %
Market Cap. Revenues TTM Net Income TTM

$ 14.549 mill.


$ 54.319 mill.


$ -39.796 mill.

Employees Shares Outstanding P/E

500


28 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 2.16 %


MRQ Y/Y - %



OABI

$4.66

$0.9200 24.60%
This Month of July


OABI

$4.66

$0.9200 24.60%



Omniab Inc

Omniab Inc shares went up 24.60% during this month of July.


Omniab Inc is a technology company that operates on a B2B (business-to-business) model, offering a range of software solutions and services. The company focuses on providing customized software applications to help businesses streamline their operations, enhance productivity, and improve efficiency. Omniab Inc also offers consultation services to assist companies in optimizing their IT infrastructure.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 469.518 mill. $ 21.046 mill. $ -63.480 mill. 101 mill. - Y/Y -77.53 %
Market Cap. Revenues TTM Net Income TTM

$ 469.518 mill.


$ 21.046 mill.


$ -63.480 mill.

Employees Shares Outstanding P/E

-


101 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -77.53 %


MRQ Y/Y - %



BFLY

$1.07

$0.2028 23.39%
This Month of July


BFLY

$1.07

$0.2028 23.39%



Butterfly Network Inc

Butterfly Network Inc stock increased 23.39% during this month of July.


Butterfly Network Inc*s business model involves developing and providing handheld ultrasound devices that are portable, affordable, and user-friendly. Their products aim to revolutionize medical imaging and provide accessible healthcare solutions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 223.495 mill. $ 67.656 mill. $ -121.921 mill. 209 mill. - Y/Y 11.63 %
Market Cap. Revenues TTM Net Income TTM

$ 223.495 mill.


$ 67.656 mill.


$ -121.921 mill.

Employees Shares Outstanding P/E

-


209 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 11.63 %


MRQ Y/Y - %



NOTV

$1.95

$0.3600 22.64%
This Month of July


NOTV

$1.95

$0.3600 22.64%



Inotiv Inc

Inotiv Inc shares improved 22.64% during this month of July.


Inotiv Inc is a contract research organization (CRO) that provides preclinical and nonclinical research services to the pharmaceutical, biotechnology, and medical device companies. The company offers a range of services including drug discovery, safety assessment, toxicology testing, and analytical services. By assisting clients with their research and development needs, Inotiv aims to contribute to the advancement of medicine and the development of new treatment options.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 50.370 mill. $ 552.744 mill. $ -71.368 mill. 26 mill. - Y/Y -21.41 %
Market Cap. Revenues TTM Net Income TTM

$ 50.370 mill.


$ 552.744 mill.


$ -71.368 mill.

Employees Shares Outstanding P/E

-


26 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -21.41 %


MRQ Y/Y - %



LWLG

$3.52

$0.6200 21.38%
This Month of July


LWLG

$3.52

$0.6200 21.38%



Lightwave Logic Inc

Lightwave Logic Inc stock improved 21.38% during this month of July.


Lightwave Logic Inc*s business model is focused on developing and commercializing advanced photonic devices and technologies for various industries.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 418.706 mill. $ 0.030 mill. $ -21.778 mill. 119 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 418.706 mill.


$ 0.030 mill.


$ -21.778 mill.

Employees Shares Outstanding P/E

10


119 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



OPGN

$3.026

$0.5230 20.89%
This Month of July


OPGN

$3.026

$0.5230 20.89%



Opgen Inc

Opgen Inc stock went up 20.89% during this month of July.


OpGen Inc*s business model revolves around providing molecular diagnostic solutions and informatics services to combat global healthcare challenges, particularly in the field of infectious diseases. They develop innovative technologies that assist healthcare professionals in identifying, treating, and preventing the spread of infectious pathogens.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4.029 mill. $ 2.673 mill. $ -26.659 mill. 1 mill. - Y/Y -81.59 %
Market Cap. Revenues TTM Net Income TTM

$ 4.029 mill.


$ 2.673 mill.


$ -26.659 mill.

Employees Shares Outstanding P/E

-


1 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -81.59 %


MRQ Y/Y - %



RNLX

$0.3

$0.0491 19.57%
This Month of July


RNLX

$0.3

$0.0491 19.57%



Renalytix Plc

Renalytix Plc stock went up 19.57% during this month of July.


Renalytix Plc is a biotechnology company that focuses on developing and commercializing diagnostic tests for kidney disease. Their business model centers around using advanced biomarkers and artificial intelligence to enhance the accuracy and speed of identifying kidney disease, ultimately improving patient outcomes. Renalytix aims to provide healthcare professionals with innovative tools that enable personalized treatments and reduce the overall burden of kidney disease on individuals and healthcare systems.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 28.430 mill. $ 6.832 mill. $ -101.037 mill. 95 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 28.430 mill.


$ 6.832 mill.


$ -101.037 mill.

Employees Shares Outstanding P/E

-


95 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



MDXH

$2.8

$0.4400 18.64%
This Month of July


MDXH

$2.8

$0.4400 18.64%



Mdxhealth Sa

Mdxhealth Sa shares increased 18.64% during this month of July.


MDxHealth SA is a biotech company that primarily focuses on developing and commercializing molecular diagnostic tests to assist healthcare professionals in making informed treatment decisions for cancer patients. Their business model revolves around providing accurate and actionable diagnostic information to improve patient outcomes and potentially reduce healthcare costs.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 72.699 mill. $ 70.193 mill. $ -43.100 mill. 26 mill. - Y/Y 89.43 %
Market Cap. Revenues TTM Net Income TTM

$ 72.699 mill.


$ 70.193 mill.


$ -43.100 mill.

Employees Shares Outstanding P/E

-


26 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 89.43 %


MRQ Y/Y - %



CDNA

$18.09

$2.7100 17.62%
This Month of July


CDNA

$18.09

$2.7100 17.62%



Caredx Inc

Caredx Inc stock increased 17.62% during this month of July.


Caredx Inc is a precision medicine company with a business model focused on transplant diagnostics. They develop and commercialize non-invasive tests to identify and monitor organ transplant rejection. By offering innovative solutions and services in the transplant field, Caredx Inc aims to improve outcomes for patients and provide healthcare professionals with valuable information to guide treatment decisions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 935.115 mill. $ 275.111 mill. $ -183.194 mill. 52 mill. - Y/Y -6.75 %
Market Cap. Revenues TTM Net Income TTM

$ 935.115 mill.


$ 275.111 mill.


$ -183.194 mill.

Employees Shares Outstanding P/E

446


52 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -6.75 %


MRQ Y/Y - %



BDSX

$1.77

$0.2400 15.69%
This Month of July


BDSX

$1.77

$0.2400 15.69%



Biodesix Inc

Biodesix Inc stock improved 15.69% during this month of July.


Biodesix Inc is a biotechnology company that utilizes advanced diagnostics to develop personalized medicine solutions for improving patient outcomes. Their business model involves leveraging their proprietary blood-based tests and data analytics to assist healthcare providers in making informed treatment decisions. By partnering with pharmaceutical companies and healthcare institutions, Biodesix aims to commercialize their innovative solutions and drive adoption in the healthcare industry.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 141.085 mill. $ 44.026 mill. $ -63.345 mill. 80 mill. - Y/Y 21.46 %
Market Cap. Revenues TTM Net Income TTM

$ 141.085 mill.


$ 44.026 mill.


$ -63.345 mill.

Employees Shares Outstanding P/E

-


80 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 21.46 %


MRQ Y/Y - %



MXCT

$4.4

$0.5700 14.88%
This Month of July


MXCT

$4.4

$0.5700 14.88%



Maxcyte inc

Maxcyte Inc stock increased 14.88% during this month of July.


Maxcyte Inc*s business model revolves around providing cell engineering and flow electroporation technology to facilitate drug discovery, development, and manufacturing processes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 457.995 mill. $ 44.054 mill. $ -36.567 mill. 104 mill. - Y/Y 32.25 %
Market Cap. Revenues TTM Net Income TTM

$ 457.995 mill.


$ 44.054 mill.


$ -36.567 mill.

Employees Shares Outstanding P/E

-


104 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 32.25 %


MRQ Y/Y - %



BIAF

$2.45

$0.2300 10.36%
This Month of July


BIAF

$2.45

$0.2300 10.36%



Bioaffinity Technologies Inc

Bioaffinity Technologies Inc stock went up 10.36% during this month of July.


Bioaffinity Technologies Inc is a biotechnology company specializing in developing and commercializing diagnostics for various medical conditions. They utilize their patented platform technology, Affinity?, which enables the detection of cancer and other diseases at an early stage through the use of biomarkers. The company focuses on licensing their technology and partnering with diagnostic companies, aiming to provide accurate, non-invasive, and cost-effective diagnostic solutions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 24.293 mill. $ 4.938 mill. $ -8.366 mill. 10 mill. - Y/Y 261,180.24 %
Market Cap. Revenues TTM Net Income TTM

$ 24.293 mill.


$ 4.938 mill.


$ -8.366 mill.

Employees Shares Outstanding P/E

-


10 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 261,180.24 %


MRQ Y/Y - %



EXAS

$46.81

$4.3800 10.32%
This Month of July


EXAS

$46.81

$4.3800 10.32%



Exact Sciences Corporation

Exact Sciences Corporation shares went up 10.32% during this month of July.


Exact Sciences Corporation is a medical diagnostics company that specializes in early cancer detection. Their business model involves developing and commercializing non-invasive, DNA-based tests for the detection of colorectal cancer, as well as other cancers and diseases. By leveraging advanced technology and partnerships with healthcare providers, Exact Sciences aims to improve patient outcomes through early detection and intervention.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 8,535.804 mill. $ 2,573.276 mill. $ -240.226 mill. 182 mill. - Y/Y 6.77 %
Market Cap. Revenues TTM Net Income TTM

$ 8,535.804 mill.


$ 2,573.276 mill.


$ -240.226 mill.

Employees Shares Outstanding P/E

5,361


182 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 6.77 %


MRQ Y/Y - %



GPFT

$0.0011

$0.0001 10.00%
This Month of July


GPFT

$0.0011

$0.0001 10.00%



Grapefruit Usa Inc

Grapefruit Usa Inc shares increased 10.00% during this month of July.


Grapefruit USA Inc operates as a fully licensed cannabis distribution and manufacturing company. They focus on producing premium, high-quality cannabis products and efficiently distributing them to licensed retailers in the United States.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 0.631 mill. $ 0.035 mill. $ -4.367 mill. 574 mill. - Y/Y -98.07 %
Market Cap. Revenues TTM Net Income TTM

$ 0.631 mill.


$ 0.035 mill.


$ -4.367 mill.

Employees Shares Outstanding P/E

-


574 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -98.07 %


MRQ Y/Y - %



BGLC

$0.5163

$0.0463 9.85%
This Month of July


BGLC

$0.5163

$0.0463 9.85%



Bionexus Gene Lab Corp

Bionexus Gene Lab Corp stock improved 9.85% during this month of July.


Bionexus Gene Lab Corp operates on a business model focused on genetic research and analysis. They provide services such as genetic testing, gene sequencing, and genetic counseling to individuals and institutions. By utilizing advanced technology and expertise, they aim to assist their clients in understanding genetic information for medical purposes and improved decision-making.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 9.122 mill. $ 9.775 mill. $ -2.664 mill. 18 mill. - Y/Y 0.20 %
Market Cap. Revenues TTM Net Income TTM

$ 9.122 mill.


$ 9.775 mill.


$ -2.664 mill.

Employees Shares Outstanding P/E

-


18 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 0.20 %


MRQ Y/Y - %



VRDN

$14.47

$1.2600 9.54%
This Month of July


VRDN

$14.47

$1.2600 9.54%



Viridian Therapeutics Inc

Viridian Therapeutics Inc shares went up 9.54% during this month of July.


Viridian Therapeutics Inc is a biotechnology company that focuses on developing novel therapeutics to treat various diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 884.103 mill. $ 0.288 mill. $ -218.125 mill. 61 mill. - Y/Y -26.53 %
Market Cap. Revenues TTM Net Income TTM

$ 884.103 mill.


$ 0.288 mill.


$ -218.125 mill.

Employees Shares Outstanding P/E

-


61 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -26.53 %


MRQ Y/Y - %



FTRE

$26.03

$2.1700 9.09%
This Month of July


FTRE

$26.03

$2.1700 9.09%



Fortrea Holdings Inc

Fortrea Holdings Inc shares increased 9.09% during this month of July.


Fortrea Holdings Inc is a company that operates through its subsidiaries in the business of software and technology services, providing innovative solutions and products to its clients. Its business model focuses on developing and delivering custom software applications, digital platforms, and consulting services to cater to the specific needs of various industries.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2,326.575 mill. $ 3,771.100 mill. $ -104.400 mill. 89 mill. - Y/Y -78.70 %
Market Cap. Revenues TTM Net Income TTM

$ 2,326.575 mill.


$ 3,771.100 mill.


$ -104.400 mill.

Employees Shares Outstanding P/E

-


89 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -78.70 %


MRQ Y/Y - %



FLGT

$21.82

$1.7800 8.88%
This Month of July


FLGT

$21.82

$1.7800 8.88%



Fulgent Genetics Inc

Fulgent Genetics Inc shares increased 8.88% during this month of July.


Fulgent Genetics Inc is a genetic testing company that offers comprehensive, flexible, and affordable genetic testing solutions for various applications, including clinical diagnostics, carrier screening, and genetic research.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 654.884 mill. $ 285.288 mill. $ -64.981 mill. 30 mill. - Y/Y -20.64 %
Market Cap. Revenues TTM Net Income TTM

$ 654.884 mill.


$ 285.288 mill.


$ -64.981 mill.

Employees Shares Outstanding P/E

284


30 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -20.64 %


MRQ Y/Y - %



GH

$30.75

$2.4900 8.81%
This Month of July


GH

$30.75

$2.4900 8.81%



Guardant Health Inc

Guardant Health Inc shares went up 8.81% during this month of July.


Guardant Health Inc*s business model revolves around providing advanced genomic testing services for cancer patients. It specializes in developing liquid biopsy tests that analyze circulating tumor DNA (ctDNA) in the blood. These tests help in early cancer detection, treatment selection, and monitoring of cancer progression. Guardant Health Inc collaborates with healthcare providers, pharmaceutical companies, and researchers to provide these innovative tests and contribute to the advancement of precision medicine in oncology.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 3,742.644 mill. $ 603.725 mill. $ -460.901 mill. 122 mill. - Y/Y 30.90 %
Market Cap. Revenues TTM Net Income TTM

$ 3,742.644 mill.


$ 603.725 mill.


$ -460.901 mill.

Employees Shares Outstanding P/E

1,100


122 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 30.90 %


MRQ Y/Y - %



VCYT

$23.18

$1.8500 8.67%
This Month of July


VCYT

$23.18

$1.8500 8.67%



Veracyte Inc

Veracyte Inc stock improved 8.67% during this month of July.


Veracyte Inc*s business model revolves around providing genomic diagnostic solutions to enable physicians to make more informed treatment decisions for patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1,732.932 mill. $ 375.473 mill. $ -68.177 mill. 75 mill. - Y/Y 17.50 %
Market Cap. Revenues TTM Net Income TTM

$ 1,732.932 mill.


$ 375.473 mill.


$ -68.177 mill.

Employees Shares Outstanding P/E

677


75 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 17.50 %


MRQ Y/Y - %



XGN

$1.96

$0.1500 8.29%
This Month of July


XGN

$1.96

$0.1500 8.29%



Exagen Inc

Exagen Inc stock improved 8.29% during this month of July.


Exagen Inc*s business model revolves around providing diagnostic testing solutions in the field of autoimmune diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 35.171 mill. $ 55.733 mill. $ 4.295 mill. 18 mill. - Y/Y 28.36 %
Market Cap. Revenues TTM Net Income TTM

$ 35.171 mill.


$ 55.733 mill.


$ 4.295 mill.

Employees Shares Outstanding P/E

-


18 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 28.36 %


MRQ Y/Y - %



INCY

$65.87

$5.0000 8.21%
This Month of July


INCY

$65.87

$5.0000 8.21%



Incyte Corporation

Incyte Corporation shares went up 8.21% during this month of July.


Incyte Corporation is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative medicines. Their business model revolves around extensive research and development efforts to identify potential drug candidates for various diseases. With a focus on oncology and other serious inflammatory conditions, Incyte aims to bring effective therapies to patients while collaborating with partners and leveraging their extensive intellectual property portfolio.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 14,966.916 mill. $ 3,767.865 mill. $ 745.444 mill. 227 mill. 20.02 Y/Y 8.93 %
Market Cap. Revenues TTM Net Income TTM

$ 14,966.916 mill.


$ 3,767.865 mill.


$ 745.444 mill.

Employees Shares Outstanding P/E

2,094


227 mill.


20.02

Revenue Growth Income Growth

MRQ Y/Y 8.93 %


MRQ Y/Y 681.22 %



IQV

$224.57

$16.0800 7.71%
This Month of July


IQV

$224.57

$16.0800 7.71%



Iqvia Holdings Inc

Iqvia Holdings Inc shares went up 7.71% during this month of July.


IQVIA Holdings Inc is a multinational company that operates in the healthcare industry. Its business model revolves around providing advanced analytics, technology solutions, and clinical research services to help clients make informed decisions, optimize their operations, and accelerate drug development. By leveraging its vast data resources and expertise, IQVIA aims to support healthcare professionals in improving patient outcomes and driving innovation in the industry.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 41,388.251 mill. $ 15,069.000 mill. $ 1,357.000 mill. 184 mill. 30.53 Y/Y 2.33 %
Market Cap. Revenues TTM Net Income TTM

$ 41,388.251 mill.


$ 15,069.000 mill.


$ 1,357.000 mill.

Employees Shares Outstanding P/E

79,000


184 mill.


30.53

Revenue Growth Income Growth

MRQ Y/Y 2.33 %


MRQ Y/Y -0.35 %



GNOM

$11.19

$0.7800 7.49%
This Month of July


GNOM

$11.19

$0.7800 7.49%



Complete Genomics Inc

Complete Genomics Inc stock went up 7.49% during this month of July.


Complete Genomics Inc operates in the field of genetic sequencing, offering end-to-end solutions for large-scale genomic research. They provide comprehensive DNA sequencing services, including sample preparation, sequencing, data analysis, and consulting, primarily catering to research institutions, pharmaceutical companies, and academic organizations.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 384.206 mill. $ 19.877 mill. $ -57.048 mill. 34 mill. - Y/Y -62.39 %
Market Cap. Revenues TTM Net Income TTM

$ 384.206 mill.


$ 19.877 mill.


$ -57.048 mill.

Employees Shares Outstanding P/E

-


34 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -62.39 %


MRQ Y/Y - %



CRL

$218.24

$15.0000 7.38%
This Month of July


CRL

$218.24

$15.0000 7.38%



Charles River Laboratories International inc

Charles River Laboratories International Inc stock improved 7.38% during this month of July.


Charles River Laboratories International Inc is a contract research organization (CRO) that provides essential services and support to the pharmaceutical, biotech, and medical device industries. They offer a wide range of research models, drug discovery and development services, safety assessments, and laboratory animal medicine to assist in the preclinical and clinical stages of drug development.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 11,313.998 mill. $ 4,111.596 mill. $ 450.898 mill. 52 mill. 25.66 Y/Y -1.73 %
Market Cap. Revenues TTM Net Income TTM

$ 11,313.998 mill.


$ 4,111.596 mill.


$ 450.898 mill.

Employees Shares Outstanding P/E

20,000


52 mill.


25.66

Revenue Growth Income Growth

MRQ Y/Y -1.73 %


MRQ Y/Y -28.35 %



NNOX

$7.64

$0.4900 6.85%
This Month of July


NNOX

$7.64

$0.4900 6.85%



Nano x Imaging Ltd

Nano X Imaging Ltd stock went up 6.85% during this month of July.


Nano X Imaging Ltd is a medical imaging technology company that aims to revolutionize the field by developing and commercializing a novel digital X-ray system. Their business model involves building partnerships with healthcare providers, imaging equipment manufacturers, and distributors to bring their innovative technology to market, providing cost-effective and accessible diagnostic solutions globally. By delivering high-quality imaging at a fraction of the cost of traditional systems, Nano X Imaging aims to improve healthcare outcomes and increase patient access to effective diagnostics.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 430.652 mill. $ 9.905 mill. $ -60.776 mill. 56 mill. - Y/Y 15.47 %
Market Cap. Revenues TTM Net Income TTM

$ 430.652 mill.


$ 9.905 mill.


$ -60.776 mill.

Employees Shares Outstanding P/E

-


56 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 15.47 %


MRQ Y/Y - %



DGX

$146.01

$8.9200 6.51%
This Month of July


DGX

$146.01

$8.9200 6.51%



Quest Diagnostics Inc

Quest Diagnostics Inc stock went up 6.51% during this month of July.


Quest Diagnostics Inc operates as a provider of clinical laboratory and diagnostic information services, serving patients, physicians, hospitals, and pharmaceutical companies. The company generates revenue by offering a range of diagnostic testing services, including laboratory analysis, test development, and specialized diagnostics.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 16,353.120 mill. $ 9,287.000 mill. $ 899.000 mill. 112 mill. 19.70 Y/Y 1.50 %
Market Cap. Revenues TTM Net Income TTM

$ 16,353.120 mill.


$ 9,287.000 mill.


$ 899.000 mill.

Employees Shares Outstanding P/E

49,000


112 mill.


19.70

Revenue Growth Income Growth

MRQ Y/Y 1.50 %


MRQ Y/Y -4.15 %



RDNT

$62

$3.4500 5.89%
This Month of July


RDNT

$62

$3.4500 5.89%



Radnet Inc

Radnet Inc stock increased 5.89% during this month of July.


Radnet Inc is a medical diagnostic imaging company that operates a network of outpatient imaging centers. Their business model focuses on offering convenient and accessible imaging services to patients, partnering with healthcare providers, and leveraging technology to ensure efficient operations. By providing advanced diagnostic capabilities and collaborating with insurance companies, Radnet Inc aims to enhance patient care and streamline the imaging process.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4,297.039 mill. $ 1,627.954 mill. $ 29.751 mill. 69 mill. - Y/Y 12.46 %
Market Cap. Revenues TTM Net Income TTM

$ 4,297.039 mill.


$ 1,627.954 mill.


$ 29.751 mill.

Employees Shares Outstanding P/E

8,700


69 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 12.46 %


MRQ Y/Y 8.92 %



GEHC

$80.44

$4.1800 5.48%
This Month of July


GEHC

$80.44

$4.1800 5.48%



Ge Healthcare Technologies Inc

Ge Healthcare Technologies Inc stock went up 5.48% during this month of July.


GE Healthcare Technologies Inc*s business model is focused on providing innovative medical devices, healthcare information technology, and healthcare services to improve patient care and outcomes. The company offers a wide range of products and solutions in areas such as medical imaging, patient monitoring, diagnostics, and healthcare IT. They also collaborate with healthcare providers and partners to offer integrated solutions and support throughout the entire healthcare ecosystem.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 36,921.960 mill. $ 16,328.000 mill. $ 1,619.000 mill. 459 mill. 23.53 Y/Y -1.50 %
Market Cap. Revenues TTM Net Income TTM

$ 36,921.960 mill.


$ 16,328.000 mill.


$ 1,619.000 mill.

Employees Shares Outstanding P/E

-


459 mill.


23.53

Revenue Growth Income Growth

MRQ Y/Y -1.50 %


MRQ Y/Y 1.31 %



HOLX

$78.11

$4.0100 5.41%
This Month of July


HOLX

$78.11

$4.0100 5.41%



Hologic Inc

Hologic Inc stock increased 5.41% during this month of July.


Hologic Inc*s business model revolves around the development, manufacturing, and commercialization of medical technology and diagnostic products, primarily focused on women*s healthcare. They aim to provide innovative solutions for various medical specialties, including breast and skeletal health, gynecological health, and surgical products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 18,555.968 mill. $ 4,046.300 mill. $ 621.900 mill. 238 mill. 29.81 Y/Y -0.85 %
Market Cap. Revenues TTM Net Income TTM

$ 18,555.968 mill.


$ 4,046.300 mill.


$ 621.900 mill.

Employees Shares Outstanding P/E

6,944


238 mill.


29.81

Revenue Growth Income Growth

MRQ Y/Y -0.85 %


MRQ Y/Y -22.24 %



ICLR

$329.7

$13.1900 4.17%
This Month of July


ICLR

$329.7

$13.1900 4.17%



Icon Plc

Icon Plc stock went up 4.17% during this month of July.


Icon Plc is a leading provider of clinical research services, specializing in the design and management of clinical trials for pharmaceutical and biotechnology companies. Their business model focuses on offering a comprehensive range of services, including study design, data management, regulatory support, and statistical analysis, to support the development of new drugs and medical devices. Icon Plc*s success lies in its ability to provide customized solutions to its clients, efficiently navigate the regulatory landscape, and consistently deliver high-quality and timely results.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 27,272.006 mill. $ 8,120.176 mill. $ 1,236.802 mill. 83 mill. 44.55 Y/Y 4.89 %
Market Cap. Revenues TTM Net Income TTM

$ 27,272.006 mill.


$ 8,120.176 mill.


$ 1,236.802 mill.

Employees Shares Outstanding P/E

15,950


83 mill.


44.55

Revenue Growth Income Growth

MRQ Y/Y 4.89 %


MRQ Y/Y 144.76 %



LH

$211.37

$8.2400 4.06%
This Month of July


LH

$211.37

$8.2400 4.06%



Laboratory Corporation Of America Holdings

Laboratory Corporation Of America Holdings stock improved 4.06% during this month of July.


Laboratory Corporation Of America Holdings operates as a leading healthcare diagnostics company. They offer a range of clinical laboratory tests and services to healthcare providers, pharmaceutical companies, and government agencies. Their business model focuses on providing accurate and timely test results, enabling healthcare professionals to diagnose, treat, and monitor patients effectively.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 17,915.375 mill. $ 11,560.300 mill. $ 434.200 mill. 85 mill. 42.70 Y/Y -15.92 %
Market Cap. Revenues TTM Net Income TTM

$ 17,915.375 mill.


$ 11,560.300 mill.


$ 434.200 mill.

Employees Shares Outstanding P/E

75,500


85 mill.


42.70

Revenue Growth Income Growth

MRQ Y/Y -15.92 %


MRQ Y/Y 7.03 %



CELC

$17.28

$0.6400 3.85%
This Month of July


CELC

$17.28

$0.6400 3.85%



Celcuity Inc

Celcuity Inc shares improved 3.85% during this month of July.


Celcuity Inc is a biotechnology company that develops and commercializes diagnostic tests designed to classify patients* specific cancer subtypes. These tests help physicians select the most appropriate targeted therapies for their patients, ultimately improving treatment outcomes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 580.816 mill. $ - mill. $ -74.498 mill. 34 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 580.816 mill.


$ - mill.


$ -74.498 mill.

Employees Shares Outstanding P/E

-


34 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



BNR

$6.5

$0.2200 3.50%
This Month of July


BNR

$6.5

$0.2200 3.50%



Burning Rock Biotech Limited

Burning Rock Biotech Limited stock went up 3.50% during this month of July.


Burning Rock Biotech Limited is a company that specializes in molecular diagnostics for cancer.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ - mill. $ 75.696 mill. $ -92.070 mill. - mill. - Y/Y -7.31 %
Market Cap. Revenues TTM Net Income TTM

$ - mill.


$ 75.696 mill.


$ -92.070 mill.

Employees Shares Outstanding P/E

-


- mill.


-

Revenue Growth Income Growth

MRQ Y/Y -7.31 %


MRQ Y/Y - %



MEDP

$421.31

$14.0700 3.45%
This Month of July


MEDP

$421.31

$14.0700 3.45%



Medpace Holdings Inc

Medpace Holdings Inc stock increased 3.45% during this month of July.


Medpace Holdings Inc is a contract research organization (CRO) that provides various services in the clinical research and development of drugs and medical devices.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 13,482.341 mill. $ 1,962.812 mill. $ 312.507 mill. 32 mill. 42.79 Y/Y 17.73 %
Market Cap. Revenues TTM Net Income TTM

$ 13,482.341 mill.


$ 1,962.812 mill.


$ 312.507 mill.

Employees Shares Outstanding P/E

3,900


32 mill.


42.79

Revenue Growth Income Growth

MRQ Y/Y 17.73 %


MRQ Y/Y 40.74 %



PHG

$25.87

$0.7900 3.15%
This Month of July


PHG

$25.87

$0.7900 3.15%



Koninklijke Philips Nv

Koninklijke Philips Nv shares increased 3.15% during this month of July.


Koninklijke Philips Nv operates as a diversified technology company, focusing on areas such as healthcare, consumer lifestyle, and lighting. The company provides a wide range of products and solutions, including medical imaging equipment, home appliances, personal care products, and lighting solutions. Philips Nv*s business model involves innovation-driven research and development, strategic partnerships, and a global distribution network to deliver its products and services to customers worldwide.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 23,638.078 mill. $ 20,349.280 mill. $ -518.560 mill. 914 mill. - Y/Y 1.92 %
Market Cap. Revenues TTM Net Income TTM

$ 23,638.078 mill.


$ 20,349.280 mill.


$ -518.560 mill.

Employees Shares Outstanding P/E

82,000


914 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 1.92 %


MRQ Y/Y - %



NRC

$23.53

$0.6300 2.75%
This Month of July


NRC

$23.53

$0.6300 2.75%



National Research Corporation

National Research Corporation stock increased 2.75% during this month of July.


National Research Corporation (NRC) operates as a healthcare research and performance measurement firm, providing insights and data-driven solutions. They collect, analyze, and interpret patient and healthcare provider feedback to assist organizations in improving their overall quality of care. NRC*s business model focuses on selling research products, licensing data services, and providing consulting solutions to healthcare organizations seeking to enhance patient experiences and outcomes.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 563.849 mill. $ 147.420 mill. $ 30.366 mill. 24 mill. 18.94 Y/Y -3.18 %
Market Cap. Revenues TTM Net Income TTM

$ 563.849 mill.


$ 147.420 mill.


$ 30.366 mill.

Employees Shares Outstanding P/E

-


24 mill.


18.94

Revenue Growth Income Growth

MRQ Y/Y -3.18 %


MRQ Y/Y -8.69 %




 1 Day   Week  Current Month of July  30 Days 
Current Quarter Q3 of 2024  90 Days    Ytd    12 Months 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com